Anti-Human CD52 (Alemtuzumab) - Dylight® 488
£304.69
Anti-Human CD52 (Alemtuzumab) - Dylight® 488 (LT211-100ug)
Product
| Cat # LT211-100ug | Size 100 µg |
Price
£304.69
|
Qty
|
Description
Clone Campath-1H is a monoclonal antibody that specifically binds to CD52, a protein present on the surface of mature lymphocytes. However, this protein is not present on the stem cells that generated these lymphocytes. Alemtuzumab is targets and destroys mature lymphocytes containing CD-52, and is used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis. Anti-Human CD52 (Alemtuzumab) utilizes the same variable regions from the therapeutic antibody Alemtuzumab making it ideal for research projects.
Specifications
| Manufacturer Cat# | LT211 |
|---|---|
| Product Size | 100 µg |
| Concentration | 0.2 mg/ml |
| Formulation | This DyLight® 488 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative. |
| Clone | Campath-1H |
| Target | CD52 |
| Applications | FA, FC, IHC FF, IHC FFPE |
| Antigen | CD52 is primarily expressed on the surface of mature lymphocytes. Additionally, CD52 is present on most lymphoid derived malignancies. However, variable expression on Myeloma cells should be noted. |
| Storage | This DyLight® 488 conjugate is stable when stored at 2-8°C. Do not freeze. |
| Protein | CD52 |